These factors, in turn, further stimulate the proliferation, invasion, and PTHrP secretion of breast cancer cells, thereby exacerbating tumor progression and bone tissue destruction (Johnson et al., 2022; Kim et al., 2023; Duong et al., 2025). The gene discussed is PTHLH; the disease is breast carcinoma.